Immunocore Holdings PLC reports results for the quarter ended in December - Earnings Summary

Immunocore Holdings

01/03/2023 14:34

* Immunocore Holdings PLC  IMCR.OQ  reported a quarterly
adjusted
loss of 54 pence​​ per share for the quarter ended in December.
The mean expectation of ten analysts for the quarter was
for breakeven results per share.
    * Revenue rose 629% to £48.06 million from a year ago;
analysts
expected £42.83 million. 
    * Immunocore Holdings PLC's reported EPS for the quarter was
a
loss of 54 pence​.
    * The mean earnings estimate of analysts had risen by
about 100%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Immunocore Holdings PLC shares had fallen by 3.9% this
quarter.
    * The company reported a quarterly loss of £25.2 million.
    * Wall Street's median 12-month price target for Immunocore
Holdings PLC is $81.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 02:34 p.m.  ​All figures in pounds unless otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.00           -0.54          Missed
 Sep. 30 2022      -0.29          0.12           Beat
 Jun. 30 2022      -0.67          -0.14          Beat
 Mar. 31 2022      -0.84          -0.37          Beat